Cargando…
Neutralizing Antibodies Targeting HIV-1 gp41
HIV-1 vaccine research has obtained an enormous boost since the discovery of many broadly neutralizing antibodies (bnAbs) targeting all accessible sites on the HIV-1 envelope glycoprotein (Env). This in turn facilitated high-resolution structures of the Env glycoprotein in complex with bnAbs. Here w...
Autores principales: | Caillat, Christophe, Guilligay, Delphine, Sulbaran, Guidenn, Weissenhorn, Winfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690876/ https://www.ncbi.nlm.nih.gov/pubmed/33114242 http://dx.doi.org/10.3390/v12111210 |
Ejemplares similares
-
Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
por: Caillat, Christophe, et al.
Publicado: (2021) -
SARS-CoV-2 S Glycoprotein Stabilization Strategies
por: Pedenko, Borys, et al.
Publicado: (2023) -
Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019) -
VPS4 triggers constriction and cleavage of ESCRT-III helical filaments
por: Maity, Sourav, et al.
Publicado: (2019) -
Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)